HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Extracorporeal membrane oxygenation. Successful treatment of persistent fetal circulation following repair of congenital diaphragmatic hernia.

Abstract
Four neonates (three having undergone repair of a congenital diaphragmatic hernia and developing a persistent fetal circulatory pattern and one having severe infant respiratory distress syndrome) have been supported with prolonged extracorporeal membrane oxygenation (ECMO) at Children's Hospital of Pittsburgh between December of 1979 and April of 1980. Three have survived. This encouraging experience indicates that the pattern of persistent fetal circulation in the newborn infant who has undergone repair of a diaphragmatic hernia can be successfully managed with ECMO even when efforts to lower pulmonary hypertension and improve oxygenation with vasodilators (tolazoline, phenothiazine, acetylcholine, or prostaglandin E1) and have been ineffective. The effectiveness and safety of ECMO is convincing enough to warrant its consideration as therapy for congenital diaphragmatic hernia and persistent fetal circulation prior to the use of vasodilators.
AuthorsR L Hardesty, B P Griffith, R F Debski, M R Jeffries, H S Borovetz
JournalThe Journal of thoracic and cardiovascular surgery (J Thorac Cardiovasc Surg) Vol. 81 Issue 4 Pg. 556-63 (Apr 1981) ISSN: 0022-5223 [Print] United States
PMID7206762 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Vasodilator Agents
Topics
  • Blood Flow Velocity
  • Blood Gas Analysis
  • Female
  • Heart-Lung Machine
  • Hernia, Diaphragmatic (surgery)
  • Hernias, Diaphragmatic, Congenital
  • Humans
  • Hypoxia (therapy)
  • Infant, Newborn
  • Male
  • Oxygenators, Membrane
  • Persistent Fetal Circulation Syndrome (therapy)
  • Respiratory Distress Syndrome, Newborn (therapy)
  • Vasodilator Agents (therapeutic use)
  • Whole Blood Coagulation Time

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: